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Abstract
OBJECTIVE: A number of factors limit the effectiveness of current aortic arch studies in assessing optimal neuroprotection strategies,
including insufﬁcient patient numbers, heterogenous deﬁnitions of clinical variables, multiple technical strategies, inadequate reporting
of surgical outcomes and a lack of collaborative effort. We have formed an international coalition of centres to provide more robust
investigations into this topic.
© The Author 2013. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery. All rights reserved.
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METHODS: High-volume aortic arch centres were identiﬁed from the literature and contacted for recruitment. A Research Steering
Committee of expert arch surgeons was convened to oversee the direction of the research.
RESULTS: The International Aortic Arch Surgery Study Group has been formed by 41 arch surgeons from 10 countries to better evaluate
patient outcomes after aortic arch surgery. Several projects, including the establishment of a multi-institutional retrospective database, ran-
domized controlled trials and a prospectively collected database, are currently underway.
CONCLUSIONS: Such a collaborative effort will herald a turning point in the surgical management of aortic arch pathologies and will
provide better powered analyses to assess the impact of varying surgical techniques on mortality and morbidity, identify predictors for
neurological and operative risk, formulate and validate risk predictor models and review long-term survival outcomes and quality-of-life
after arch surgery.
Keywords: Aortic arch surgery • Database • Cerebral protection
INTRODUCTION
Aortic arch surgery had been especially challenging for surgeons,
largely because of the need to interrupt blood ﬂow to the brain
and to the downstream organs, mandated as part of the operative
strategy. In 1954, DeBakey reported his ﬁrst arch repair [1], but
it was not until cardiopulmonary bypass was introduced that
DeBakey et al. were able to replace the aortic arch successfully.
Since then, surgical management of aortic arch pathologies has
evolved signiﬁcantly. Recognizing the importance of neuroprotec-
tion as the cornerstone of a successful surgical outcome, Griepp
et al. [2] popularized hypothermic circulatory arrest (HCA) as an
obligatory component of arch surgery in 1975. Although sufﬁcient
hypothermia can reduce systemic and cerebral metabolic
demands, it is not possible to completely suspend metabolic ac-
tivity. As a result, adjunctive measures, such as retrograde cerebral
perfusion (RCP) and selective antegrade cerebral perfusion
(SACP), have been utilized to support lingering cerebral metabol-
ism, particularly during prolonged periods of circulatory arrest.
While modern pioneers continue to push the boundaries of
surgery to reﬁne operative techniques, such a rapid progress in
surgical techniques has outpaced the availability of robust clinical
evidence, despite voluminous observational studies. This inad-
equacy of data-driven literature has signiﬁcantly curtailed the de-
velopment of evidence-based guidelines. The International Aortic
Arch Surgery Study Group (IAASSG) has been formed by 41 aca-
demic surgeons from 34 cardiac centres and 10 countries to
address this issue. We aim to conduct the ARCH Projects, includ-
ing establishing a multi-institutional retrospective database, ran-
domized controlled trials (RCTs) and a prospective registry, that
will provide robust clinical information with sufﬁcient statistical
power on patient management and prognostication. Furthermore,
with the introduction of hybrid and endovascular arch repairs,
traditional arch surgery is at a critical junction [3–5]. This collabora-
tive endeavour will establish benchmarks for existing surgical and
neuroprotective techniques, so as to provide a platform for direct-
ing future avenues of research.
THE INTERNATIONAL AORTIC ARCH SURGERY
STUDY GROUP
The main objectives of the IAASSG are 4-fold: (i) to determine the
optimal neuroprotection strategies and operative parameters
for patients undergoing hemi-arch and total arch surgery; (ii) to
assess perioperative mortality, morbidities and predictors for
operative risk; (iii) to formulate a risk predictor model in arch
surgery and (iv) to evaluate long-term survival outcomes and
quality-of-life after aortic arch surgery.
IAASSG SCIENTIFIC COMMITTEE
The Scientiﬁc Committee consists of members of the Collaborative
Research (CORE) Group, (www.coregroupinternational.org), which is
composed of a highly experienced team of cardiothoracic surgeons,
research fellows, systematic reviewers and biostatisticians from
Australia, the USA and the UK (Table 1). The CORE Group is
responsible for the concept, design and establishment and funding
of the ARCH Projects, as well as performance of statistical analyses,
coordination of research projects and management of administra-
tive tasks.
IAASSG Research Steering Committee
The direction and progress of the ARCH Projects will be overseen
by the Research Steering Committee, which consists of 19 aca-
demic surgeons from high-volume aortic centres (Table 1). The
Research Committee will provide overall guidance and supervi-
sion of any research. The development of research projects and
publications will be made by consensus with >50% concurrence.
IAASSG participating centres
Thirty-four tertiary institutions are partaking in this international
project and are representative of high-volume aortic centres
across the world. This should minimize variation in patient demo-
graphics and surgical skills, thus enabling broader acceptance and
application of results. All participating centres are eligible to apply
through the Research Steering Committee to perform research
projects from the multi-institutional database.
STUDY DESIGN
To achieve the outlined objectives, the IAASSG is conducting re-
search projects in the following ﬁve coordinated steps. These are (i)
systematically evaluating current literature; (ii) achieving clinical
consensus; (iii) establishing the ARCH Project (I)—Multi-institutional
Retrospective Database; (iv) conducting the ARCH Project (II)—
Multi-institutional RCTs and (v) forming the ARCH Project (III)—
Multi-institutional Prospective Registry. For more details, please
visit the IAASSG website: www.archprojects.org.
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Step 1: systematically evaluating current literature
Meta-analyses and systematic reviews of the current literature
have been performed by the IAASSG through May 2013, using
electronic databases such as Ovid Medline, EMBASE, ACP Journal
Club, Cochrane Database of Systematic Reviews, Cochrane Central
Register of Controlled Trials and Database of Abstracts of Review
of Effectiveness. The keywords and MeSH terms included: ‘aortic
arch surgery’ or ‘aneurysm, dissecting’, or ‘aorta, thoracic’, or
‘aortic aneurysm’ and ‘circulatory arrest’ or ‘circulatory arrest, deep
hypothermia induced’. Of 1127 references identiﬁed, 178 studies
reported outcomes for patient series of ≥100. A summary of four
primary neuroprotection strategies of interest, including deep
hypothermic circulatory arrest (DHCA) alone, DHCA + RCP,
DHCA + SACP or moderate hypothermic circulatory arrest
(MHCA) + SACP, is presented below, as these represent the most
widely practised and established techniques.
Deep hypothermic circulatory arrest. Since ﬁrst introduced in
1975 [2], DHCA has underpinned the practice of arch surgery. In
shorter operations, DHCA sufﬁciently reduces cerebral metabolic
demand to enable circulatory arrest without signiﬁcant deleterious
neurological outcomes. Mortality for DHCA has been reported to
be between 2 and 11%, with stroke rates between 4 and 14% [6, 7].
Patients operated on using deep hypothermic conditions can
tolerate 20–30 min of circulatory arrest, which in general is long
enough for hemi-arch repairs, while 22–98% of these patients also
achieved electrocerebral silence [8, 9]. However, it has been
noted, mostly through laboratory studies, that hypothermia pre-
disposes to enzyme and organ dysfunction, exacerbates bleeding,
lengthens duration of bypass and aggravates systemic inﬂamma-
tory responses [6]. Furthermore, low temperatures increase blood
viscosity and impair the release of O2 to the tissues due to left-
shift of the oxygen-dissociation curve. The relative paucity of clin-
ical data on the impact of deep hypothermia in visceral organs
requires further investigation.
Deep hypothermic circulatory arrest + retrograde cerebral
perfusion. DHCA + RCP in arch surgery was ﬁrst described by Ueda
and associates in 1990 [10], with the belief that retrograde perfusion
would enable metabolic sustenance to the brain and prevent
neurological embolic events [11]. However, its acceptance as an
effective neuroprotection strategy has diminished signiﬁcantly in
recent years, particularly after Ehrlich et al. [12] demonstrated in a
porcine model that only 0.01% of retrograde perfusate through the
superior vena cava traverses the brain capillaries, therefore disproving
the raison d’être of RCP. Nevertheless, prior studies demonstrated
mortality rates of 3.9–13.6% and stroke rates of 2.6–11.8% [11, 13, 14],
and this technique is still recently practised by some [14].
Deep hypothermic circulatory arrest + selective antegrade
cerebral perfusion. DHCA + SACP has gained recent
prominence as a preferred neuroprotection strategy for complex
arch surgeries, as the ability to perfuse the brain during circulatory
arrest supports any lingering cerebral metabolism not moderated
by deep hypothermia. Reported mortality ranges from 3.9 to 16%
and stroke ranges between 5.6 and 14% [6, 15]. However, concerns
have been raised regarding the time required to rewarm the
patient, the risk of introducing emboli due to cannulation of
supra-aortic vessels and the potential deleterious effects of deep
hypothermia on other organs.
A meta-analysis by IAASSG comparing DHCA with
DHCA + SACP showed that adjunctive SACP reduces mortality
rates (8.5 vs 15.2%; P = 0.008); other outcomes, such as neurologic-
al deﬁcit, were either comparable or inadequately reported [16].
Moderate hypothermic circulatory arrest + selective
antegrade cerebral perfusion. The closer proximity of
MHCA + SACP to normal physiology is now considered an attractive
option for many surgeons. By using moderate hypothermia, some
of the risks of deep hypothermia may be obviated, while sufﬁcient
cerebral metabolic supply is maintained [17, 18].
A separate meta-analysis conducted by IAASSG assessing the
existing evidence for neuroprotection strategies in aortic arch
surgery showed that MHCA + SACP is more advantageous in redu-
cing stroke rates compared with DHCA alone (7.3 vs 12.8%;
P = 0.0007) [19]. A key ﬁnding from this study is the paucity and in-
consistency of the reporting of systemic outcomes. Indeed, only
renal failure and bleeding were reported reliably to enable statis-
tical analysis.
Table 1: International Aortic Arch Surgery Study Group
Research Steering
Committee
Institution
Tristan D. Yan The Collaborative Research (CORE) Group, Macquarie
University (Sydney, Australia)
Scott A. LeMaire Baylor College of Medicine/Texas Heart Institute
(Houston, TX, USA)
Martin Misfeld Heart Center, University of Leipzig (Leipzig, Germany)
John A. Elefteriades Yale University School of Medicine (New Haven, CT,
USA)
Edward P. Chen Emory University (Atlanta, GA, USA)
G. Chad Hughes Duke University Medical Center (Durham, NC, USA)
Randall B. Griepp Mount Sinai School of Medicine (New York City, NY,
USA)
Nicholas
T. Kouchoukos
Missouri Baptist Medical Center (St. Louis, MO, USA)
Paul G. Bannon University of Sydney, Royal Prince Alfred Hospital
(Sydney, Australia)
Joseph E. Bavaria Hospital of the University of Pennsylvania
(Philadelphia, PA, USA)
Joseph S. Coselli Baylor College of Medicine/Texas Heart Institute
(Houston, TX, USA)
Roberto Di
Bartolomeo
Sant’Orsola-Malpighi Hospital (Bolonga, Italy)
Marco Di Eusanio Sant'Orsola-Malpighi Hospital (Bologna, Italy)
Axel Haverich Hannover Medical School (Hannover, Germany)
Friedrich W. Mohr Heart Center, University of Leipzig (Leipzig, Germany)
Aung Oo Liverpool Heart and Chest Hospital (Liverpool, UK)
Hazim J. Safi The Texas Heart Institute at St. Luke’s Episcopal
Hospital (Houston, USA)
Malakh Shrestha Hannover Medical School (Hannover, Germany)
Malcolm
J. Underwood
Prince of Wales Hospital (Hong Kong, China)
CORE Group Role
Tristan D. Yan Chairman
Paul G. Bannon Clinical Governance/Ethics
Scott A. LeMaire Aortic Research Advisor
Malcolm
J. Underwood
Cardiac Research Advisor
David H. Tian CORE Research Fellow
Marco Di Eusanio CORE Project Coordinator
Anneke Damberg Researcher
Ratnasari Padang Researcher
Kevin Phan Researcher
Aaron Weiss Researcher
Deborah Black Biostatistician
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Limitation of existing studies. Despite the apparent wealth of
information, these observational studies and meta-analyses are
not adequate for addressing our objectives outlined above.
Furthermore, the current literature is limited by a number of
factors, including:
(i) Heterogeneous deﬁnitions of clinical variables.
(ii) Confounding factors that cannot be controlled or adjusted
without original data.
(iii) Insufﬁcient reporting of postoperative outcomes.
(iv) Low patient numbers and inadequately powered individual
studies.
In addition to the perfunctory status of the literature, several
obstacles inherent to the nature of aortic arch surgery have hin-
dered robust evaluation of operative techniques:
(i) Low prevalence of patients that require surgery in a single
centre; accumulating large number of patients will take a
prolonged period, during which time the surgical strategies
may have evolved and the ‘best approach’ at the time may
become out-dated.
(ii) Variations in surgical techniques that confound statistical ana-
lysis—this includes arrest temperature, perfusate temperature,
cannulation site, neuroprotection adjuncts, etc. As none of
the small-scale case series provided deﬁnitive answers for
neuroprotection, the same questions are likely to continue to
be debated in the coming decade.
(iii) Aortic arch surgery is a highly complex operation and usually
performed at specialized aortic centres; small single-centre
cohorts do not ensure study quality and applicability.
Step 2: achieving clinical consensus
A further limitation of the existing literature is the lack of standar-
dized deﬁnitions and reporting criteria for several critical vari-
ables. For example, despite its ubiquitous application, no
consistent deﬁnition exists for the varying ranges of hypothermia
during circulatory arrest. Such inconsistencies hinder the validity
of comparisons between institutional reports, thus curtailing the
evidence-based evolution of surgical practice. Consensus needs to
be reached to standardize reporting formats in order to improve
the validity of future institutional studies.
Consensus on hypothermia classiﬁcation. The IAASSG has
already achieved two important Consensuses among international
aortic arch surgeons. A Consensus Statement published by
members of the IAASSG Research Steering Committee has
standardized the deﬁnitions of hypothermia to include profound
(≤14°C), deep (14.1–20°C), moderate (20.1–28°C) or mild
hypothermia (≥28°C), to be measured at the nasopharynx [8].
Consensus on clinical endpoints. Additionally, a key ﬁnding of
the above literature review is the deﬁcient reporting of systemic
clinical outcomes. While the majority of studies focused on
mortality and neurological adverse events, morbidities such as renal,
respiratory and cardiovascular outcomes were poorly reported. To
overcome this, a Consensus Survey of important clinical endpoints
that must be reported after arch surgery, along with their grading
system, has been conducted by the IAASSG. A consensus has been
achieved by 45 aortic surgeons from 40 high-volume aortic arch
institutions and 12 countries. This report is in preparation for
publication and will ensure uniformity and consistency between
future documentations of clinical outcomes.
Step 3: the ARCH Project (I)—Retrospective
Database
Presently, only a few studies with sufﬁcient patient numbers have
been conducted to compare surgical techniques and outcomes.
While the literature is replete with observational studies, demo-
graphic and technique heterogeneities between institutions pre-
clude robust examination of critical variables and endpoints.
Existing RCTs comparing neuroprotective techniques in adult
aortic arch surgery are insufﬁciently powered to determine sur-
vival outcomes [20–22]. Based on the results of a RCT investigating
neurocognitive functions after arch surgery with HCA, HCA + SACP
or HCA + RCP, Svensson et al. [22] concluded that 650 patients are
required for a study to be sufﬁciently powered just to evaluate the
role of RCP in reducing stroke rate. Existing multi-institutional
databases, such as the International Registry for Aortic Dissection
(IRAD) and German Registry for Acute Aortic Dissection Type A
(GERAADA), have been unable to conclusively evaluate variations
in surgical techniques. For example, a major shortcoming of IRAD
is its lack of detailed technical surgical data [23]. By the same
token, while >50 institutions are partaking in GERAADA, they are
all from the same geographic area and lack long-term follow-up
[24]; such geographic bias may introduce confounding population
health and epidemiological factors, as well as potentially limiting
the generalizability of surgical techniques and outcomes. Results
from these two registries are further limited by the lack of risk
stratiﬁcation and the focus on aortic dissection, which overlooks
other aetiologies.
To overcome these limitations, and to provide convincing evi-
dence for different surgical techniques, a multicentre database for
operations involving the aortic arch is required to better compare
overall survival outcomes. The collaborative pooling of data will
generate hypotheses, identify prognostic factors, assess optimal
operative strategies and aid in the formulation of evidence-based
surgical guidelines. Furthermore, this will enable an evaluation of
the inﬂuence that cerebral perfusion strategy, temperature and
the location of cannulation have on patient outcomes such as
mortality and neurological dysfunction.
Participating centres. Institutions that have published series
between 2000 and 2013 with >100 aortic arch operations have
been contacted and invited to submit their prospectively collected
data. Expert advice was sought from the Research Steering
Committee regarding recruitment of other centres. Thirty-four
institutions from 10 countries have already agreed to participate
(Fig. 1), with recruitment of additional centres anticipated.
Patients and methods. Ethics approval is obtained from
participating institutions through their institutional review boards
or through the chairperson of the ethics committee, who will
waive the need for patient consent for the study as individual
patients will not be identiﬁed. The study population is deﬁned as
patients who were considered for hemi-arch or total arch
replacement surgery between 2000 and 2013 from the
participating international institutions. The inclusion criteria are
aortic arch pathologies (elective or emergent) and treatment
strategies that utilized hemi-arch replacement, total arch
replacement or an endovascular approach. Paediatric patients will
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be excluded. Standardized clinical data on consecutive patients
from each of the participating institutions will be entered into a
central database. Follow-up data from most recent reviews will
also be included. Each institution must conﬁrm that the pooled
data represent consecutive operative procedures performed in
the study period by participating surgeons.
Standardized data form. A data list of variables of interest will
be created to retrieve relevant information. The variables included
in this list have been found to have signiﬁcant prognostic values in
other studies or because they may have potential clinical
implications for future patient management. These blinded data
will be collected electronically.
Figure 1: Participating institutions in the ARCH Project (I)—Retrospective Database.
Figure 2: Long-term strategic plan for the International Aortic Arch Surgery Study Group.
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Step 4: the Arch Project (II)—Randomized
Controlled Trials
Results from the retrospective database will guide the next phase of
aortic arch surgical research, involving the design of multi-
institutional RCTs (Fig. 2). Indeed, several authors have concluded
that RCTs are required to convincingly assess optimal surgical prac-
tice [6, 25]. The RCTs should be conducted separately in patients
undergoing hemi-arch and total arch replacements. For hemi-arch
cases, treatment arms favoured include DHCA alone, DHCA + RCP,
DHCA + SACP and MHCA + SACP. For total arch replacement,
patients are randomized to DHCA + SACP vs MHCA + SACP. This
will provide the highest level of evidence for neuroprotection in
aortic arch surgery. Consensus needs to be reached on the details
of surgical strategies for each treatment arm.
Step 5: the ARCH Project (III)—prospective registry
Participation in RCTs is entirely voluntary. Patients not eligible for
randomization or from centres where randomization is not pos-
sible or deemed unnecessary will be entered into a prospective
registry. This open-ended registry will serve as a platform for
ongoing evaluation of evolving surgical practice.
In addition, the IAASSG will formulate an acceptable standar-
dized methodological protocol for the collection, preservation
and storage of plasma and aortic tissue material in order to hom-
ogenize and facilitate large-scale collaborative and integrated bio-
markers and omics research into aortic arch pathologies. Protocol
details will include complete proband phenotype characterization
and collection, and processing and storage methods of biological
samples for downstream application.
CONCLUSION
The establishment of the ARCH projects will promote closer collab-
oration among all centres and allow sufﬁciently powered statistical
analyses for risk factor prediction, longitudinal assessment and
propensity-scored analysis. By amalgamating multi-institutional
clinical data and matching patients with similar risk factors and con-
founding variables who underwent different treatment strategies, it
will be possible to test for hypotheses regarding optimal neuropro-
tection strategies for hemi-arch and total arch replacements.
Ultimately, deﬁnitive answers will be provided through prospective
RCTs. Such a collective effort will herald a turning point in the surgi-
cal management of aortic arch pathologies.
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